Regulation of protein kinase C δ by estrogen in the MCF-7 human breast cancer cell line

Molecular and Cellular Endocrinology

Volumn 148, Issue 1-2, 1999, Pages 109-118

  Shanmugam, Malathy ^a   Krett, Nancy L ^a   Maizels, Evelyn T ^a   Cutler Jr , Richard E ^a   Peters, Carl A ^a   Smith, Leia M ^a   O'Brien, Michelle L ^b   Park Sarge, Ok Kyong ^b   Rosen, Steven T ^a   Hunzicker Dunn, Mary ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Breast cancer; Estrogen; PKC ; Signal transduction

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR; PROTEIN KINASE C; RECEPTOR SUBTYPE;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; DOWN REGULATION; GENE EXPRESSION; GENE EXPRESSION REGULATION; GRANULOSA CELL; HUMAN; HUMAN CELL; OVARY CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

ANIMALS; BREAST NEOPLASMS; CORPUS LUTEUM; ESTRADIOL; ESTROGEN ANTAGONISTS; ESTROGENS; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GRANULOSA CELLS; HUMANS; ISOENZYMES; POLYUNSATURATED ALKAMIDES; PROTAMINE KINASE; PROTEIN KINASE C; PROTEIN KINASE C-DELTA; RABBITS; RATS; RECEPTORS, ESTROGEN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0033602123     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0303-7207(98)00229-9     Document Type: Article

References (57)

1. Berra E., Diaz-Meco M.T., Dominguez I. et al. Protein kinase C zeta isoform is critical for mitogenic signal transduction. Cell. 74:1993;555-563.
2. Berthois Y., Katzenellenbogen J.A, Katzenellenbogen B.S. Phenol red in tissue culture media is a weak estrogen: implications concerning the study of estrogen-responsive cells in culture. Proc. Natl. Acad. Sci. 83:1986;2496-2500.
3. Bignon E., Ogita K., Kishimoto A., Nishizuk Y. PKC subspecies in ER-positive and negative human breast cancer cell lines. Biochem. Biophys. Res. Comm. 171:1990;1071-1078.
4. Blobe G.M., Sachs C.W., Khan W.A. et al. Selective regulation of expression of PKC isotypes in MDR-resisitant MCF-7 cells. Functional significance of enhanced expression of PKC-alpha. J. Biol. Chem. 266:1993;658-664.
5. 2+-dependent protein kinase of human mammary carcinoma cells: inverse relationship to estrogen receptors. lnt. J. Cancer. 40:1987;344-348.
6. Borner C., Ueffing M., Jaken S., Parker P.J., Weinstein I.B. Two closely related isoforms of protein kinase C produce reciprocal effects on the growth of rat fibroblasts. J. Biol. Chem. 270:1995;78-86.
7. Burnette W.N. Western blotting: electrophoretic transfer of proteins from sodium dodecyl sulfate-polyacylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A. Anal. Biochem. 112:1981;195-203.
8. Byers M., Kuiper G.G.J.M., Gustafsson J.-A., Park-Sarge O.K. Estrogen receptor-beta mRNA expression in rat ovary: down-regulation by gonadotropins. Mol. Endocrinol. 11:1997;172-182.
9. Chirgwin J.J., Przbyla A.E., MacDonald R.J., Rutter W.J. Isolation of biologically active RNA from sources enriched in ribonuclease. Biochemistry. 18:1979;5294-5299.
10. Cormier E.M., Wolf M.F., Jordan V.C. Decrease in estradiol-stimulated progesterone receptor production in MCF-7 cells by epidermal growth factor and possible clinical implication for paracrine-regulated breast cancer growth. Cancer Res. 49:1989;576-580.
11. Cutler R.E. Jr., Maizels E.T., Hunzicker-Dunn M. Delta protein kinase-C in the rat ovary: estrogen regulation and localization. Endocrinology. 135:1994;1669-1678.
12. Dekker L.V., Parker P.J. Protein kinase C: a question of specificity. TIBS. 19:1994;73-77.
13. deVente J.E., Carey J.O., Bryant W.O., Pettit G.J., Ways D.K. Transcriptional regulation of insulin receptor substrate 1 by protein kinase C. J. Biol. Chem. 271:1996;32276-32280.
14. Dickson R.B., Lippman M.E. Estrogenic regulation of growth and polypeptide growth factor secretion in human breast carcinoma. Endocrinol. Rev. 8:1987;29-43.
15. Fabbro D., Regazzi R., Costa S.D., Borner C., Eppenberger U. Protein kinase C desensitization by phorbol esters and its impact on growth of human breast cancer cells, Biochem. Biophys. Res. Comm. 135:1986;65-73.
16. Geiges D., Marks F., Gschwendt M. Loss of protein kinase C delta from human HaCaT keratinocytes upon ras transfection is mediated by TGF alpha. Exp. Cell Res. 219:1995;299-303.
17. Harris J.R., Lippman M.E., Veronesi U., Willett W. Breast Cancer. N. Engl. J.Med. 327:1992;390-398.
18. Hickey G.J., Krasnow J.S., Beattie W.G., Richards J.S. Aromatase cytochrome P450 in rat ovarian granulosa cells before and after luteinization adenosine 3′,5′-monophosphate-dependent and independent regulation. Cloning and sequencing of rat aromatase cDNA and 5′ genomic DNA. Mol. Endocrinol. 4:1990;3-12.
19. Huggins C., Grand L.C., Brillantes F.P. Mammary cancer induced by a single feeding of poly-nuclear hydrocarbons, and its suppression. Nature. 189:1961;204-207.
20. Kennedy M.J., Pestigiamco L.J., Tyler G., May W.S., Davidson N.E. Differential effects of bryostatin 1 and phorbol ester on human breast cancer cell lines. Cancer Res. 52:1992;1278-1283.
21. Kenney N.J., Saeki T., Gottardis M. et al. Expression of Transforming Growth Factor Alpha Antisense mRNA Inhibits the Estrogen-Induced Production of TGF-alpha and Estrogen-Induced Proliferation of Estrogen-Responsive Human Breast Cancer Cells. J. Cell. Physiol. 156:1993;497-514.
22. Kielbassa K., Muller H.J., Meyer H.E., Marks F., Gschwendt M. Protein kinase C delta-specific phosphorylation of the elongation factor eEF-lalpha and an eEF-lalpha peptide at threonine 431. J. Biol. Chem. 270:1995;6156-6162.
23. Kikkawa U, Minakuchi R, Takai Y., Nishizuka Y. Calcium-activated, phospholipid-dependent protein kinase (protein kinase C) from rat brain. Meth. Enzymol. 99:1983;288-298.
24. Korach K.S. Insights from the study of animals lacking functional estrogen receptor. Science. 266:1994;1524-1527.
25. Kuiper G.G.J.M., Enmark E., Pelto-Huikko M., Nilsson S., Gustafsson J.-A. Cloning of a novel estrogen receptor expressed in rat prostate and ovary. Proc. Natl. Acad. Sci. 93:1996;5925-5930.
26. Kuiper G.G.J.M., Gustafsson J.-A. The novel estrogen receptor-beta subtype: potential role in cell- and promoter-specific actions of estrogens and anti-estrogens. FEBS Lett. 410:1997;87-90.
27. Leach K.L., McGuire J.C., Powers E.A. Characterization of a polyclonal antibody to protein kinase C. Adv. Second Messenger Phosphoprot. Res. 21A:1988;182A.
28. Lee S.A., Karaszkiewica J.W., Anderson W.B. Elevated level of nuclear PKC in multidrug-resistant MCF-7 human breast carcinoma cells. Cancer Res. 52:1992;3750-3759.
29. Lehel C., Olah Z., Jakab G., Anderson W.B. Protein kinase C epsilon is localized to the golgi via its zinc-finger domain and modulates golgi function. Proc. Natl. Acad. Sci. 92:1995;1406-1410.
30. Lippman M., Bolan G., Huff K. The effects of estrogens and antiestrogens on hormone-responsive breast cancer in long-term tissue culture. Cancer Res. 36:1976;4595-4601.
31. Lowry O.W., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
32. Lubahn D.B., Moyer J.S., Golding T.S., Couse J.F., Korach K.S., Smithies O. Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene. Proc. Natl. Acad. Sci. 90:1993;11162-11166.
33. Maizels E.T., Ekstrom R.C., Miller J.B., Hunzicker-Dunn M. Protein phosphorylation in the corpus luteum. J. Reprod. F. 37:1989;311-317.
34. Maizels E.T., Miller J.B., Cutler R.E. Jr. et al. Calcium-independent phospholipid/diolein-dependent phosphorylation of a soluble ovarian Mr 80 000 substrate protein: biochemical characteristics. Biochem. Biophys. Acta. 1054:1990;285-296.
35. Maizels, E.T, Jackiw, V, Miller, J.B, Cutler Jr., R.E, Carney, E.M., Hunzicker-Dunn, M., 1991. Variant diacylglycerol-dependent protein phosphotransferase activity in ovarian tissues. In: Geula Gibori (Ed.) Signaling Mechanisms and Gene Expression in the Ovary, Springer-Verlag, New York, pp. 54-67.
36. 2+-independent lipid-stimulated kinase in the rabbit corpus luteum of pseudopregnancy. J. Biol. Chem. 267:1992;17061-17068.
37. Maizels E.T., Shanmugam M., Lamm M.L.G., Hunzicker-Dunn M. Hormonal regulation of PKC-delta protein and mRNA levels in the rabbit corpus luteum. Mol. Cell. Endocrinol. 122:1996;213-221.
38. Mischak H., Goodnight J., Kolch W. et al. Overexpression of protein kinase C-delta and -epsilon in NIH eTe cells induces opposite effects on growth, morphology, anchorage dependence, and tumorigenicity. J. Biol. Chem. 268:1993;6090-6096.
39. Mishima K., Ohno S., Shitara N., Yamaoka K., Suzuki K. Opposite effects of the overexpression of protein kinase Cgamma and delta on the growth properties of human glioma cell line U251 MG. Biochem. Biophys. Res. Comm. 201:1994;363-372.
40. Mizuno K., Kubo K., Saido T.C. et al. Structure and properties of a ubiquitously expressed protein kinase C, nPKC delta. Eur. J. Biochem. 202:1991;931-940.
41. Normanno N., Ciardiello F., Brandt R., Salomon D.S. Epidermal growth factor-related peptides in the pathogenesis of human breast cancer. Breast Cancer Res. Treat. 29:1994;11-27.
42. O'Brian C.A., Vogel C.G., Singletary S.E., Ward N.E. Elevated PKC expression in human breast tumor biopsies relative to normal breast tissue. Cancer Res. 49:1989;3215-3217.
43. Olivier A.R., Parker P.J. Expression and characterization of protein kinase C-delta. Eur. J. Biochem. 200:1991;805-810.
44. Paech K., Webb P., Kuiper G.G.J.M., Nilson S., Gustafsson J.Å., Kushner P.J., Scanlan T.S. Differential ligand activation of estrogen receptors ERalpha and ERbeta at API sites. Science. 277:1997;1508-1510.
45. Peters, C.A., Cutler Jr., R.E., Maizels, E.T., Robertson, M.C. and Hunzicker-Dunn, M. 1999, Regulation of PKC δ expression by estrogen and rPL-1 in luteinized granulosa cells. Submitted.
46. 2+-dependent protein kinase in human breast cancer cells. Int. J. Cancer. 37:1986;731-737.
47. Richards J.S., Hedin L., Caston L. Differentiation of rat ovarian thecal cells: evidence for functional luteinization. Endocrinology. 118:1986;1660-1668.
48. Robinson S.P., Jordan V.C. Antiestrogenic action of tamoxifen on hormone-dependent, -independent, and heterogenous breast tumor growth in the athymic mouse. Cancer Res. 49:1989;1758-1762.
49. Saido T.S., Mizuno K., Konno Y., Osada S.-I., Ohno S., Suzuki K. Purification and characterization of protein kinase C epsilon from rabbit brain. Biochemistry. 31:1992;482-490.
50. Shanmugam, M., Krett, N.L. (in preparation).
51. Soule H.D, McGrath C.M Estrogen responsive proliferation of clonal human breast carcinoma cells in athymic mice. Cancer Lett. 10:1980;177-189.
52. Stanwell C., Gescher A., Bradshaw T.D., Pettit G.R. The role of protein kinase C isoenzymes in the growth inhibition caused by bryostatin 1 in human A549 lung and MCF-7 breast carcinoma cells. Int. J. Cancer. 56:1994;585-592.
53. Telleria C.M., Zhong L., Deb S. et al. Differential expression of the estrogen receptors alpha and beta in the rat corpus luteum of pregnancy: regulation by prolactin an placental lactogens. Endocrinology. 139:1998;2432-2442.
54. Wakeling A.E., Bowler J. Steroidal pure antioestrogens. J. Endocrinol. 112:1987;7-10.
55. Watanabe T., Ono Y., Taniyama Y. et al. Cell division arrest induced by phorbol ester in CHO cells overexpressing protein kinase C-delta subspecies. Proc. Natl. Acad. Sci. 89:1992;10159-10163.
56. Ways D.K., Kukoly C.A., deVente J. et al. MCF-7 breast cancer cells transfected with protein kinase C-alpha exhibit altered expression of other protein kinase C isoforms and display a more aggressive neoplastic phenotype. J. Clin. lnvest. 95:1995;1906-1915.
57. Welsch C.W. Host factors affecting the growth of carcinogen-induced rat mammary carcinomas: a review and tribute to Charles Brenten Huggins. Cancer Res. 45:1985;3415-3443.